The holidays, family gatherings and holiday celebrations are often filled with fun, good food and alcohol on occasion. Individuals with alcohol addiction may be vulnerable during this time, especially if they’re being invited to places with booze. Ideally, not having alcohol around would be best, but that isn’t always possible. Addiction psychiatrist Dr. Lauren Grawert gives a few tips on how to handle situations like this.
Grawert states that it’s good to have a preplanned response ready when you, as a recovering alcohol addict, are offered an alcoholic drink. She highlights that it should be something you’re comfortable saying. Here are a couple of examples that can be tweaked and used:
In addition, you can also have an accountability partner who knows about your situation. This person will not be drinking, just like you, and will help you get out of any offers to drink alcohol. It should be noted, however, that this is potentially risky, especially if your partner isn’t reliable.
Additionally, it is important to keep in mind that making a change may be overwhelming, especially when trying to recover from addiction. Grawert advises that those trying to change should take it one day at a time, and if you find that overwhelming, try taking it one hour at a time.
She adds that you shouldn’t give up if you relapse, explaining that you can still continue with your journey and succeed in recovering from addiction. The addiction psychiatrist recommends that those seeking resources on addiction recovery visit the website for the Substance Abuse and Mental Health Services Administration.
Many companies, including Cybin Inc. (NYSE American: CYBN) (NEO: CYBN), are working to bring to market superior formulations made from novel pharmaceutical active ingredients so that patients can enjoy better outcomes from their addiction treatment.
NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
For long, researchers have posited that a link between our brain and gut contributes to…
Researchers in China have discovered a way to supercharge the treatment of lung cancer by…
Izotropic’s IzoView Breast CT Imaging System represents a breakthrough in dedicated breast imaging technology, addressing…
Breast cancer continues to be the most commonly diagnosed cancer among U.S. women, excluding nonmelanoma…
A recent survey undertaken by Gallup in 2025 found that since 2021, there has been…
The trial targets never-smoker non-small cell lung cancer (“NSCLC”) patients, a group with limited treatment…